Insider sale
TERNS PHARMACEUTICALS, INC.
$91.1K
13.94K shares
What this filing means
VIVO CAPITAL SURPLUS FUND VIII, L.P. plans to sell 13.94K shares of TERNS PHARMACEUTICALS, INC. valued at approximately $91.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/3/2024ACC: 0000048966-24-000011
10% Owner
Since Feb 2021
13.94K
Shares to sell
$91.1K
Approx. market value
5.44K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
IPO Allocation
Cash
2/4/2021
5.44KTotal acquired5.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/4/2021 | IPO Allocation Cash | 5.44K | — |
| Total | 5.44K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.05K
Market value
$20.3K
4/3/2024
—Completed
Units to sell
5.45K
Market value
$38.1K
4/1/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
5.44K
Market value
$32.7K
4/3/2024
Total
Units
13.94K
Value
$91.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/3/2024 | 3.05K | $20.3K | — | Completed |
4/1/2024 | 5.45K | $38.1K | — | Completed |
| Planned — Approximate Date | ||||
4/3/2024 | 5.44K | $32.7K | Nasdaq | Planned |
| Total | 13.94K | $91.1K | ||